Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists – a retrospective analysis of nationwide registry data in Denmark Discussion
Article Sidebar
Main Article Content
Abstract
Combined therapy of aspirin, clopidogrel, and vitamin K antagonists are commonly used in patients after myocardial infarction, however data for the safety of combinations are sparse. The article presents the risk of hospital admission for bleeding associated with different antithrombotic regimens, based on the retrospective analysis of nationwide registers in Denmark.
To the analysis, 40 812 patients aged 30 years or older who had been admitted to hospital with first-time myocardial infarction between 2000 and 2005 were involved.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)